Algeta ASA (ALGETA.OL)
|Market Cap (Mil.):||kr15,351.78|
|Shares Outstanding (Mil.):||43.92|
OSLO/LONDON - Bayer has offered to pay $2.4 billion for Norway's Algeta , its partner for a new prostate cancer treatment, at a 27 percent premium to the stock's last close, Algeta said on Tuesday. | Video
* Bid at 27 percent premium to Algeta share price at Monday's close
Nov 26 - Algeta CFO Oystein Soug tells Reuters: * Norwegian drugmaker "has great prospects on a stand-alone basis", after Bayer bids $2.4 billion for company * For more news, please click here
FRANKFURT, Nov 26 - A spokesman for Bayer confirmed on Tuesday the German pharmaceutical group has made an offer to buy Norway's Algeta but said the company did not want to provide any details at this point.
OSLO, Nov 26 - Norwegian drug maker Algeta has received a 336 crown per share preliminary takeover bid from Germany's Bayer, valuing the company at 14.76 billion crowns ($2.41 billion), it said on Tuesday.
FRANKFURT/OSLO - German pharmaceutical group Bayer is preparing a bid to acquire Algeta, its partner for its prostrate cancer treatment Xofigo, a German newspaper reported on Tuesday.
FRANKFURT/OSLO, Nov 26 - German pharmaceutical group Bayer is preparing a bid to acquire Algeta , its partner for its prostrate cancer treatment Xofigo, a German newspaper reported on Tuesday.
OSLO, Nov 6 - Norway's Algeta, which has developed a novel prostate cancer drug with Germany's Bayer , reported a smaller-than-expected loss on Wednesday and raised slightly its estimates for 2013 revenues and marketing costs.
* Kadcyla approved in Japan, recommended for approval in EU
HELSINKI, Sept 4 - The following stocks may be affected by newspaper reports and other factors on Wednesday:
Earnings vs. Estimates
Analyst Research Reports
Algeta ASA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.